Drug intelligence / Profile preview

hirsutenone

Development stage
Preclinical
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical, Oral, Intravenous, Rectal
01

Overview

Hirsutenone is a naturally occurring diarylheptanoid compound primarily isolated from the bark and leaves of Alnus species, such as Alnus japonica and Alnus nepalensis. It exhibits a range of biological activities including anti-inflammatory, anti-tumor, immunomodulatory, and chemopreventive effects. Mechanistically, hirsutenone acts as an inhibitor of Proto-oncogene serine/threonine-protein kinase Akt1/2 by direct binding in an ATP-noncompetitive manner and suppresses downstream mTOR signaling. It also inhibits inflammatory mediators by suppressing Toll-like receptor 4 expression-mediated Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) activation regulated via the ERK pathway. Hirsutenone has demonstrated protective effects on epithelial tight junctions through activation of Epidermal growth factor receptor/Akt and Extracellular signal-regulated kinase 1/2 pathways leading to increased heme oxygenase-1 (HO-1) expression. Preclinical studies suggest potential applications in cancer (notably prostate cancer), inflammatory skin diseases, atopic dermatitis, and inflammatory bowel disease.

Other names
(4E)-1,7-bis(3,4-dihydroxyphenyl)-4-hepten-3-one
02

Targets

AKT2 (Rac-beta serine/threonine-protein kinase)TLR4 (Toll-like receptor 4)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)MAPK3 (Mitogen-activated protein kinase 1)EGFR (Epidermal growth factor receptor)NFKB1 (NF-κB1)

Beyond the preview

Go deeper on hirsutenone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hirsutenone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call